Welcome to BiotechBlog. I am Yali Friedman and I publish on the business of biotechnology. Subscribe via RSS feed or email to receive site updates!
I’ve just published a new book, by Michael L. Salgaller, PhD. In Biotechnology Entrepreneurship: From Science to Solutions Michael combines the voices of a diverse set of industry insiders with extensive experience in biotechnology commercialization to prepares nascent founders, managers, investors, and other biotechnology company stakeholders to position themselves and their companies for commercial success. [...]
{ 0 comments }
I will be moderating a panel on the roles of biotechnology in development at the upcoming A Better World by Design conference at Brown University. The theme of the panel will be the promise and challenges of implementing biotechnology advances for public benefit, with a focus on topics such as disease prevention, agricultural improvements, and [...]
{ 0 comments }
I’ve posted a new Drug Patent Challenge Report at thinkPharm.com. This new report complements the Drug Patent Inventor Report and Orphan Drug Report and profiles the companies that successfully challenged pharmaceutical drug patents. The Drug Patent Challenge Report includes: A list of the companies with the most successful patent challenges A list of all the [...]
{ 0 comments }
Drug Patent Expirations in September 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration MUSE Vivus alprostadil 5,242,391 Sep 7, 2010 ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate RE40045 Sep 7, 2010 ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate RE40045 Sep 7, 2010 ZINECARD Pharmacia And [...]
{ 1 comment }
I’ve posted a new Orphan Drug Report at thinkPharm.com. This new report complements the Drug Patent Inventor Report, and profiles pharmaceutical drugs with FDA Orphan Drug Exclusivity. The Orphan Drug Report includes: The tradename, applicant, ingredient, and Orphan exclusivity expiration dates for each Orphan Drug Details on each NDA and product number, including Dosage, Strength, [...]
{ 1 comment }
Coming soon, a book by Michael L. Salgaller, PhD. In this new book — Biotechnology Entrepreneurship: From Science to Solutions — Michael combines the voices of a diverse set of industry insiders with extensive experience in biotechnology commercialization to prepares nascent founders, managers, investors, and other biotechnology company stakeholders to position themselves and their companies [...]
{ 0 comments }
